Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Long-Term-Liabilities" stands at 49.01 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of Merck & Company Inc's third quarter, the item "Total Long Term Liabilities" stands at 49.01 Billion USD. This represents an increase of 15.52 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 12.97 percent compared to the value the year prior.
The 1 year change in percent is 12.97.
The 3 year change in percent is 23.89.
The 5 year change in percent is 22.15.
The 10 year change in percent is 29.08.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Long Term Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Long Term Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Long Term Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Long Term Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Long Term Liabilities | 280,205,508,085.11 |